Search Results - "Nesterovskiy, Yu E"
-
1
Efficacy and safety of a daytime anxiolytic containing technologically processed antibodies to the S100 protein. Overview of clinical studies
Published in Nevrologii͡a︡, neĭropsikhiatrii͡a︡, psikhosomatika (04-07-2023)“…The review presents the results of clinical studies of the efficacy and safety of Tenoten and Tenoten children’s in the treatment of anxiety, neurotic,…”
Get full text
Journal Article -
2
Paroxysmal disorders in the long-term after traumatic brain injury in children and adolescents
Published in Èpilepsiâ i paroksizmalʹnye sostoâniâ (Online) (01-03-2019)“…Consequences of traumatic brain injury (TBI) in children and adolescents pose a major medical and social problem, as TBI interferes with neuro ontogenesis…”
Get full text
Journal Article -
3
Preventive treatment of tension headache in children and adolescents
Published in Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2017)“…To assess the efficacy of noophen (γ-amino-β-phenylbutyric acid hydrochloride) in the preventive treatment of tension-type headache (TTH) in children and…”
Get more information
Journal Article -
4
Possibilities of preventive treatment of tension-type headache in children and adolescents
Published in Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2016)“…To study clinical characteristics mechanisms and pathogenesis of the tension-type headache (TTH) in children and adolescents treated with nooclerin. The blind…”
Get more information
Journal Article -
5
Anxiety disorders as comorbid conditions in neuropsychiatric diseases in children
Published in Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2024)“…The variants of heterotypic comorbidity of anxiety disorders (AD) with attention deficit hyperactivity disorder, autism spectrum disorders, speech and language…”
Get more information
Journal Article -
6
Features of neurological manifestations of the COVID-19 in children and adults
Published in Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2020)“…The number of COVID-19 patients is increasing worldwide and the number of patients with neurological manifestations of a new coronavirus infection is…”
Get more information
Journal Article